echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Jincheng Pharma's wholly-owned subsidiary Adenosylmethionine butanedisulfonate passed CDE approval

    Jincheng Pharma's wholly-owned subsidiary Adenosylmethionine butanedisulfonate passed CDE approval

    • Last Update: 2022-03-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the evening of February 9, Jincheng Pharmaceutical announced that its wholly-owned subsidiary, Jincheng Bio, submitted its application for the registration of "adenosylmethionine butanedisulfonate" non-sterile APIs that have passed the Center for Drug Evaluation (CDE) of the State Food and Drug Administration.
    ) for approval
    .


    Adenosylmethionine is a physiologically active molecule that exists in all tissues and body fluids of the human body.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.